183 filings
Page 3 of 10
8-K
uq362njn
25 Jun 21
Regulation FD Disclosure
7:36am
8-K
wrhecz
25 May 21
Pieris Pharmaceuticals Superior Medicines Through Efficient Biology Corporate Presentation May 2021
8:06am
8-K
ata bpn3r9b43d03pcz
25 May 21
Entry into a Material Definitive Agreement
8:05am
8-K
hkoafem cp
21 May 21
Entry into a Material Definitive Agreement
4:52pm
8-K
51v65chx uj3hkwx7dtq
17 May 21
Results of Operations and Financial Condition
7:05am
8-K
m2h8 vn3aye1s6fmkjx
26 Apr 21
Entry into a Material Definitive Agreement
8:55am
8-K
ch0lklq qa47bybc
12 Apr 21
Regulation FD Disclosure
9:55am
8-K
sxc9 tvdqk1y2t8tqz
30 Mar 21
Results of Operations and Financial Condition
7:40am
8-K
bkxc2kugrs80ec2g
30 Mar 21
Entry into a Material Definitive Agreement
7:16am
8-K
pabosk1jbqas5qx
25 Mar 21
Entry into a Material Definitive Agreement
8:51am
8-K
0qpjhmkn ccfmid
15 Dec 20
Investor Presentation December 2020
8:35am
8-K
00ifpnx0534m766rr
4 Nov 20
Results of Operations and Financial Condition
7:01am
8-K
dgssd1zf5zk
21 Sep 20
PRS-343 Esmo Update September 2020
11:06am
8-K
d8l9h5409f
21 Sep 20
Regulation FD Disclosure
7:56am
8-K
x687z
9 Sep 20
Investor Presentation September 2020
9:14am
8-K
k7gls
10 Aug 20
Pieris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:45am
8-K
8i6 lxffjsz
10 Aug 20
Entry into a Material Definitive Agreement
7:40am
8-K
ikjj3d
20 Jul 20
Pieris Pharmaceuticals Announces Partial Clinical Hold on PRS-343
4:12pm
8-K
r1a9e7 a5v70
29 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
3rtvya
8 Jun 20
Other Events
5:19pm